Industry
Dade Behring and Euro-Diagnostica to Develop Arthritis Test
Dade Behring has signed a license and cooperation agreement with Euro-Diagnostica whereby Dade acquires the rights to use the cyclic citrullinated peptides (CCP) of Euro-Diagnostica in a new test for rheumatoid arthritis (RA). More...05 Dec 2006
In Other News
Abbott Gets Worldwide Rights to Market Platelet Test
Israeli Scientist to Develop "Electronic Nose”
Emerging Technologies Boost European IVD Markets
Roche Obtains Rights to Diagnostic Growth Factor
Biosensor Systems to Aid Forensic Analysis
Diagnostics Company Wins Patent Battle
Using Nucleic Acids From Urine for Diagnostics
Grant Awarded for Breast Cancer Biomarker Validation
MDS Sells Diagnostics Business for $1.19 Billion
The Expanding European Market for Immunodiagnostics
Orchid Cellmark Awarded Forensic DNA Contracts
Iris Diagnostics to Supply Microscopy Technology to LabCorp
bioMérieux Acquires Microbial Genotyping Technology
Stratagene Acquires Rights to Predictive Genes for Bladder Cancer
Nobel Prize Winner to Address Annual Pathology Meeting
Epigenomics to Use Affymetrix Technology for IVD Tests
China to Expand Neonatal Screening
Worldwide POC Diagnostics Market to Grow
BD to Build Manufacturing Plant in China
Olympus America Acquires Bacus Labs
Beckman Coulter Adopts Verification System
Companies Merge to Form Diagnostics Firm
Siemens Stages Entry as New Diagnostics Powerhouse
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.








